MDMA (Ecstasy) Holds Promise for Chronic Treatment-Resistant PTSD

Published July 20, 2010

MDMA (Ecstasy) holds promise for chronic treatment-resistant PTSD
MDMA (-3,4-methylenedioxymethamphetamine, also known as Ecstasy), may one day offer hope for individuals with posttraumatic stress disorder (PTSD), even people for whom other treatments have failed. Clinical trial results out today in the Journal of Psychopharmacology, published by SAGE, suggests that MDMA can be administered to subjects with PTSD without evidence of harm and could offer …
Read more on News-Medical-Net